‘I wanted to bang my head’: How a delayed shingles diagnosis caused much suffering
Salma Khalik's nightmare began on Oct 23, when she felt a pain on the right side of her mouth and jaw. Read more at ...
FiercePharma5d
Fierce Pharma Asia—Sanofi's $1B manufacturing base; GSK's ADC deal, Shingrix recalibration in China
Sanofi unveiled a plan to build a $1 billion manufacturing site in Beijing while completing construction at a plant in ...
Pharmabiz6d
GSK and Zhifei revise and extend strategic vaccine collaboration in China
GSK and Zhifei revise and extend strategic vaccine collaboration in China: London, UK Friday, December 6, 2024, 10:00 Hrs [IST] GSK plc announced that it has entered into an agree ...
devdiscourse6d
Health Sector Transformation: Market Deals and Legal Verdicts
This briefing covers significant developments in health, including a revised deal between GSK and China's Zhifei, FDA ...
MM&M6d
Five things for pharma marketers to know for Friday morning
A single mutation in the H5N1 bird flu virus may make it more infectious to humans; New evidence from UnitedHealthcare CEO murder emerges.
GSK Expands Vaccine Collaboration With Zhifei in China
GSK expands the licensing deal with Zhifei to market its shingles vaccine in China for an additional eight years till 2034.
The Pharma Letter6d
GSK expands vaccine collaboration in China with Zhifei
UK pharma major GSK has into an agreement with Chongqing Zhifei Biological Products (Zhifei) to revize the terms on which ...
FiercePharma6d
GSK cuts Shingrix deliveries in revised Zhifei China pact, moves closer to RSV vaccine deal
Under the revised agreement, the two have taken their RSV commitment a step forward as Zhifei agrees to engage exclusively ...